Procaterol

This classification denotes an adrenergic beta-2 receptor agonist, bronchodilator agent, and sympathomimetic with the molecular formula C16H22N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X7I3EMM5K0, chemically known as 8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1h)-quinolinone (r*,s*)-(+-)- but generally known as procaterol, which bears US NIH Compound Identifier 4916. European Medicines Agency schedules Procaterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10058MIG. World Health Organization schedules procaterol in its Anatomical Therapeutic Chemical (ATC) Classification. PROCATEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule procaterol under HS 29337900 and SITC 51561. As of Q4 2014, PROCATEROL remains the US FDA Preferred Term for this commodity. SMILES: OC(C(NC(C)C)CC)C1C2C([NH]C(=O)CC2)C(O)CC1.